Titan Biotech Limited (BOM:524717)
422.85
-3.20 (-0.75%)
At close: Jun 17, 2025
Titan Biotech Revenue
In the fiscal year ending March 31, 2025, Titan Biotech had annual revenue of 1.56B INR, down -4.65%. Titan Biotech had revenue of 351.69M in the quarter ending March 31, 2025, a decrease of -11.90%.
Revenue
1.56B
Revenue Growth
-4.65%
P/S Ratio
2.23
Revenue / Employee
3.48M
Employees
449
Market Cap
3.49B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 1.56B | -76.21M | -4.65% |
Mar 31, 2024 | 1.64B | 200.73M | 13.94% |
Mar 31, 2023 | 1.44B | 204.50M | 16.55% |
Mar 31, 2022 | 1.24B | -186.92M | -13.14% |
Mar 31, 2021 | 1.42B | 628.00M | 79.05% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,646.93B |
HDFC Bank | 2,728.47B |
Tata Consultancy Services | 2,553.24B |
Bharti Airtel | 1,729.85B |
ICICI Bank | 2,006.54B |
State Bank of India | 3,429.39B |
Infosys | 1,647.16B |
Life Insurance Corporation of India | 8,901.58B |